Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $250.00K in the quarter ending June 30, 2025, a decrease of -76.70%. This brings the company's revenue in the last twelve months to $250.00K, down -99.64% year-over-year. In the year 2024, Repare Therapeutics had annual revenue of $53.48M with 4.58% growth.

• Revenue (ttm): $250.00K
• Revenue Growth: -99.64%
• P/S Ratio: 271.10
• Revenue / Employee: $1,938
• Employees: 129
• Market Cap: 68.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.48M	2.34M	4.58%
Dec 31, 2023	51.13M	-80.70M	-61.21%
Dec 31, 2022	131.83M	124.23M	1,634.61%
Dec 31, 2021	7.60M	7.47M	5,529.63%
Dec 31, 2020	135.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.